全科医疗中良性前列腺增生的回顾与更新
Review and update of benign prostatic hyperplasia in general practice.
作者信息
Jiwrajka Manasi, Yaxley William, Perera Marlon, Roberts Matt, Dunglison Nigel, Yaxley John, Esler Rachel
机构信息
BA, MBBS, MPhil candidate, Resident Medical Officer, Urology Department, Royal Brisbane and Women@s Hospital, Brisbane, Qld; Faculty of Medicine, The University of Queensland, Brisbane, Qld; Queensland Institute of Medical Research, Brisbane, Qld.
MBBS, Resident Medical Officer, Associate Lecturer, Urology Department, Royal Brisbane and Women@s Hospital, Brisbane, Qld; Faculty of Medicine, The University of Queensland, Brisbane, Qld.
出版信息
Aust J Gen Pract. 2018 Jul;47(7):471-475. doi: 10.31128/AFP-08-17-4292.
BACKGROUND
Benign prostatic hyperplasia (BPH) is the most common benign tumour in men. Although men with BPH often need medical or surgical management from a urologist at some point throughout the timeline of their disease, most men are initially assessed and managed by a general practitioner (GP) in the primary healthcare setting.
OBJECTIVE
The aim of this article is to highlight the principles of the pathogenesis, presentation, assessment and management of BPH in a primary care setting.
DISCUSSION
Between 2009 and 2011, BPH was managed by GPs at approximately 228,000 general practice visits per annum in Australia. Several changes in pharmaceutical agents and surgical intervention have occurred over the past decade. As a result, it is imperative that GPs remain up to date with assessment and management of BPH, are aware of new therapies and understand when to refer to a urologist.
背景
良性前列腺增生（BPH）是男性最常见的良性肿瘤。虽然患有BPH的男性在其疾病进程中的某个时间点通常需要泌尿外科医生进行药物或手术治疗，但大多数男性最初是在初级医疗保健机构由全科医生（GP）进行评估和治疗的。
目的
本文旨在强调在初级保健环境中BPH的发病机制、临床表现、评估和治疗原则。
讨论
2009年至2011年期间，澳大利亚每年约有22.8万次全科诊疗中，BPH由全科医生进行治疗。在过去十年中，药物和手术干预发生了一些变化。因此，全科医生必须与时俱进，了解BPH的评估和治疗，知晓新疗法，并明白何时转诊给泌尿外科医生。
Zotero 插件